Advertisements

Chloramine (Chlorphenamine)

Quick links to important sections

Chloramine (Chlorphenamine)

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Chloramine (Chlorphenamine)

Quick Facts

Property Description
Active Ingredient Chlorphenamine maleate
Form Tablet, syrup, injection
Pharmacological Class First-generation Antihistamine
Common Use Allergic conditions
Origin Synthetic

What Type of Medicine is Chloramine (Chlorphenamine)?

Chlorphenamine (INN: Chlorpheniramine) is a first-generation Antihistamine belonging to the alkylamine derivative chemical class. This synthetic compound is the active ingredient in preparations sometimes referenced by the common name Chloramine. Its fundamental purpose is to generally counteract the effects of histamine, the substance responsible for mediating most allergic symptoms. Chlorphenamine is utilized for its efficacy as an H1 receptor antagonist for addressing acute allergic reactions. The medicine is clinically intended to interrupt the body's overreaction to allergens by blocking the key chemical messenger. Unlike many newer antihistamines, Chlorphenamine possesses a characteristic lipophilicity that allows it to access the central nervous system, a feature that results in recognized sedative properties inherent to its class.


Composition and Pharmaceutical Forms

The active component is predominantly utilized as Chlorphenamine maleate (C20H23ClN2O4), which is the stable salt form of the core chemical entity. As a single-active ingredient product, Chlorphenamine is presented in various pharmaceutical preparations to facilitate effective delivery. The formulations include conventional tablets, liquid forms such as syrup and oral solution, and specialized dosage forms like extended-release capsules. While primarily intended for oral administration, it is also manufactured as a sterile solution for injection for acute clinical needs, ensuring adaptability across clinical settings, including the rapid management of severe hypersensitivity reactions under medical supervision.

Regulatory References

  1. National Institutes of Health (NIH) Drug Information
  2. MedlinePlus
Advertisements

What side effects are possible with Chloramine (Chlorphenamine)?

Possible Side Effects and Safety Information

The following section outlines the officially documented adverse effects and safety characteristics of Chlorphenamine, based strictly on government regulatory documents.


Frequency-Classified Adverse Reactions

Adverse reactions are grouped by their incidence as categorized in regulatory labeling:

Classification Examples of Documented Effects
Very Common Sedation, Somnolence (Drowsiness)
Common Disturbance in attention, Abnormal coordination, Dizziness, Headache, Blurred vision, Nausea, Dry mouth, Fatigue
Frequency Unknown Palpitations, Tachycardia, Confusion, Irritability, Nightmares, Urinary retention, Rash, Photosensitivity, Anaphylactic reactions, Blood dyscrasias, Hepatitis, Jaundice

Serious and Clinically Significant Reactions

Regulatory documents list certain rare but serious adverse reactions, including severe hypersensitivity responses such as Anaphylactic reactions, as well as severe blood disorders like Haemolytic anaemia and other Blood dyscrasias.


Population-Specific Safety Notes

  • Children and the Elderly: These groups are noted as being more likely to experience neurological anticholinergic effects and paradoxical excitation (e.g., restlessness).
  • Pregnancy and Lactation: Use during the third trimester may result in reactions in the newborn. Use during lactation is generally not recommended as the substance may inhibit milk production and be secreted into breast milk.

Safety-Related Restrictions

Use requires caution in individuals with certain pre-existing conditions, including epilepsy, conditions causing raised intra-ocular pressure (such as glaucoma), prostatic hypertrophy, severe hypertension or cardiovascular disease, and respiratory conditions like asthma or bronchitis. Caution is also advised in patients with severe renal or hepatic impairment.

Advertisements

Overdose and Emergency Response

Chloramine (Chlorphenamine) overdose is officially documented in regulatory information as potentially presenting with a wide range of neurological and physiological effects. Overdose manifestations may include both central nervous system (CNS) depression, such as profound somnolence and deepening coma, and CNS excitation, including paradoxical excitation, tremors, and convulsions or seizures. Anticholinergic signs, such as mydriasis, hyperpyrexia, and toxic psychosis, are also documented clinical manifestations.

Regulators state that overdose may progress to life-threatening outcomes, including cardiovascular collapse, cardiac arrhythmias, apnoea, and ultimately cardiac arrest. Due to these potential severe effects, the official guidance mandates that individuals must seek immediate medical attention or call emergency services upon any suspicion of overdose.

There is no specific antidote available for Chlorphenamine overdose. Management is therefore defined as symptomatic and supportive measures, requiring interventions such as constant cardiac monitoring and the vigorous treatment of documented complications like hypotension. Furthermore, official labeling notes that children and the elderly are more susceptible to severe neurological anticholinergic effects and paradoxical excitation.

Advertisements

Therapeutic Uses of Chloramine (Chlorphenamine)

What Chloramine (Chlorphenamine) treats: main uses and benefits

Chlorphenamine (also known as chlorpheniramine) is a first-generation antihistamine primarily used to manage symptoms associated with various allergic conditions. By blocking H1 receptors in the body, it prevents the action of histamine, a chemical released during an allergic reaction.

Allergic Rhinitis (Hay Fever)

Chlorphenamine is frequently used to provide temporary relief from the symptoms of seasonal and perennial allergic rhinitis. This includes conditions triggered by pollen, pet dander, dust mites, and mold spores. The medication helps address:

  • Sneezing
  • Itchy, runny, or blocked nose
  • Itchy, red, or watery eyes
  • Itching of the throat or roof of the mouth

Urticaria and Skin Allergic Reactions

The medication is effective in managing several types of skin-related allergic responses. It can reduce the discomfort associated with:

  • Urticaria (Hives): Relieving the itching and reducing the appearance of raised, red welts on the skin.
  • Angioedema: Assisting in the reduction of swelling in deeper layers of the skin.
  • Pruritus: Alleviating general itching associated with skin rashes or insect bites.

Common Cold Symptom Relief

While it does not treat the virus itself, chlorphenamine is often included in multi-symptom cold formulations. Its anticholinergic properties help dry up nasal secretions, providing relief from a runny nose and post-nasal drip often associated with the common cold.

Other Uses

Chlorphenamine may also be utilized in the management of other histamine-mediated conditions, such as:

  • Allergic Conjunctivitis: Reducing redness and irritation in the eyes.
  • Food Allergies: Managing mild skin or nasal symptoms resulting from food sensitivities (though it is not a treatment for severe anaphylaxis).
  • Drug Reactions: Providing relief for mild skin eruptions caused by reactions to other medications.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Chlorphenamine is generally suitable for adults and children over one year of age, though specific age restrictions may vary by product formulation (e.g., tablets often for ages six and up). Frail, elderly patients should use caution due to an increased risk of side effects like confusion, and may require a lower dose.


Contraindications and Cautions

Chlorphenamine is not suitable for all individuals. You should not take this medication if you are allergic to chlorphenamine or any other ingredients in the formulation, or if you are currently taking a Monoamine Oxidase Inhibitor (MAOI) or have taken one within the last 14 days. It is also generally advised to avoid use during pregnancy and breastfeeding unless a doctor deems it essential, as its safety has not been fully established and it passes into breast milk.


Caution and medical consultation are necessary if you have conditions that could be aggravated by the drug's anticholinergic effects. These include:

  • Glaucoma (specifically narrow-angle)
  • Prostatic hypertrophy (enlarged prostate) or difficulty urinating
  • Epilepsy or a history of seizures
  • Asthma or other lower respiratory diseases (e.g., chronic bronchitis)
  • Severe high blood pressure or cardiovascular disease
  • Liver or kidney problems
  • Thyrotoxicosis (overactive thyroid)
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

Classification Interacting Entity Official Regulatory Statement
Contraindicated Monoamine Oxidase Inhibitors (MAOIs) Formally contraindicated due to the risk of intensifying anticholinergic and central nervous system effects.
Pharmacokinetic Phenytoin Chlorphenamine inhibits the hepatic metabolism of Phenytoin, potentially leading to increased serum concentrations and risk of toxicity.
Pharmacodynamic CNS Depressants & Alcohol May cause additive CNS depression (e.g., increased sedation) with alcohol, opioids, anxiolytics, and hypnotics.
Pharmacodynamic Anticholinergic Drugs May result in additive adverse effects related to cholinergic blockade.

Interaction-Related Constraints and Restrictions

Timing-based interaction rules:

A mandatory time separation of 14 days is required after the cessation of Monoamine Oxidase Inhibitor (MAOI) therapy before the administration of Chlorphenamine.

Substance Restrictions:

Co-administration with Alcohol should be avoided as it potentiates sedative effects. Concurrent use with other antihistamine-containing products is restricted to prevent cumulative effects.

Population-specific interaction notes:

Regulatory documents indicate that the elderly and children are more susceptible to experiencing heightened neurological anticholinergic effects, such as increased drowsiness and confusion, when interactions occur.


Connection to the Overall Interaction Profile

The regulatory profile for Chlorphenamine is primarily defined by pharmacodynamic potentiation with central nervous system-acting and anticholinergic medicines, and a specific pharmacokinetic liability due to its inhibitory effect on the metabolism of Phenytoin. These patterns establish both formal contraindications and specific use-with-caution rules for several medicinal product classes, detailing restrictions on co-administration timing and co-ingestion with alcohol.

Advertisements

Mechanism of Action

The mechanism of action of Chlorphenamine (Chlorpheniramine), a first-generation alkylamine antihistamine, primarily involves modulation of receptor-mediated signaling pathways at the molecular level.

Histamine H1 Receptor Antagonism

Chlorphenamine functions as a competitive inverse agonist at the histamine H1 receptor. By binding to this receptor, the drug prevents the activation typically caused by endogenous histamine released during heightened immune activity. This interaction modifies the intracellular signaling cascades, which typically involve Gq protein coupling, thereby altering the physiological responses that drive increased vascular permeability and vasodilation.

Central H1 Activity and Muscarinic Modulation

As a lipophilic agent, Chlorphenamine readily crosses the blood-brain barrier to engage H1 receptors within the central nervous system. This binding event affects central histaminergic activity, leading to subsequent effects on alertness. Additionally, the drug exhibits anticholinergic activity by binding to muscarinic acetylcholine receptors (mAChRs), which contributes to the modulation of downstream autonomic pathway signaling.

Advertisements

Dosage and Administration Information

How to Use Chloramine (Chlorphenamine)

The use of Chlorphenamine is subject to specific protocols regarding the approved routes of administration, standard dosing regimens, and required procedural constraints.

Administration Routes and Forms

Chlorphenamine is available for administration via the oral route in formulations such as tablets (e.g., 4 mg immediate-release) and syrup or oral solution. A sterile solution for injection is also used for Intravenous (IV), Intramuscular (IM), or Subcutaneous (SC) administration in acute clinical settings.

Standard Dosing and Frequency

Feature Adult Instruction (Ages 12 and older) Maximum Limit Dosing Interval
Oral (Immediate-Release) 4 mg per dose 24 mg in 24 hours Every 4 to 6 hours
Oral (Extended-Release) 12 mg per dose 24 mg in 24 hours Every 12 hours

For oral formulations, a minimum interval of four hours must be maintained between immediate-release doses. The medicine can be taken with or without food.

Administration Requirements

  1. Measuring Liquid Dose: Syrups must be measured with an accurate milliliter measuring device.
  2. Extended-Release Forms: Tablets designed for extended release must be swallowed whole and should not be crushed, broken, or chewed.
  3. IV Administration: When administered intravenously, the injection must be given slowly over a period of one minute.

Population Adjustments

Children (aged 6 to under 12 years) typically use a lower dose of 2 mg or 5 mL syrup every 4 to 6 hours. Older adults are often prescribed a lower daily dose, such as a maximum of 12 mg in 24 hours, due to increased sensitivity.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of studies for Chloramine (Chlorphenamine)

The research evidence for chloramine (chlorphenamine) is built primarily on studies that examined its use for allergic conditions. The findings reported reflect patterns observed under the specific conditions of the clinical trials.


Evidence for Use in Allergic Rhinitis and Allergic Conjunctivitis

Research was evaluated in studies exploring chloramine for conditions involving periods of heightened symptoms, such as hay fever (allergic rhinitis) and allergic conjunctivitis. These studies have largely consisted of short-term, randomized controlled trials (RCTs) and comparative studies that explore how symptoms change over time. Researchers primarily examined outcomes related to physical discomfort, monitoring changes in total symptom scores for issues like sneezing, runny nose, itching, and watery eyes. The trials reported data showing patterns related to how symptoms changed in the observed populations during the study period.

However, certain research limitations persist. The follow-up durations were limited, meaning long-term effects are not fully established regarding the durability of symptom control over many months or years. Comparative evidence is lacking from recent head-to-head monotherapy trials, meaning research does not determine whether an individual will respond similarly to other H1-antagonists studied.


Evidence for Use in Urticaria (Hives)

Chloramine was evaluated in studies for urticaria (hives). The research base includes controlled clinical trials and literature reviews that monitored outcomes related to physical discomfort in studies conducted during periods of increased symptom activity. Study populations comprised adults with acute or chronic idiopathic urticaria. Key research focused on measuring changes in pruritus (itching intensity) and the visible manifestations of hives. What remains uncertain is the study of long-term outcomes for chronic urticaria, as follow-up durations were often limited to several weeks.


Evidence for Use as Adjunctive Support for Common Cold Symptoms

This medicine was observed in research exploring its role in managing symptoms of the common cold, specifically when symptoms become more noticeable. This evidence is derived from systematic reviews that have pooled data from numerous older, short-term randomized controlled trials (RCTs) of fixed-dose combination products. A major research limitation is the data for monotherapy: comparative evidence is lacking for chloramine used alone to treat cold symptoms, and the certainty remains low due to the methodological issues and age of many pooled trials.

Key Studies & References

  1. Chlorpheniramine: StatPearls
  2. Chlorpheniramine: Drug Information
  3. The role of first-generation H1-antihistamines in the management of allergic rhinitis: a systematic review
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Chloramine (Chlorphenamine) (FAQ)


Q: Is Chloramine (Chlorphenamine) the same medicine as Chlorpheniramine?

Yes, according to official drug information, Chlorphenamine and Chlorpheniramine are both commonly used names for the same active ingredient, which is typically found as Chlorpheniramine Maleate. Regulatory agencies and chemical databases recognize these names as referring to the identical compound.


Q: How quickly should the effects of Chlorphenamine be expected to start working?

Official drug documentation indicates that the onset of action for this medicine generally begins within one to two hours after administration. This is the period within which the body starts to absorb the active ingredient.


Q: How long do the anti-allergy effects of Chlorphenamine typically last after a single administration?

Studies and regulatory summaries report that the effects of Chlorphenamine generally last for approximately four to six hours following a single dose. This duration is one factor in determining the necessary dosing interval.


Q: Is the generic form of the drug chemically identical to the brand-name version (e.g., Piriton)?

Regulatory documents confirm the active component is the same chemical compound (Chlorphenamine Maleate) in both generic and brand-name formulations. This means the active ingredient is identical across these products.


Q: Can I take Chlorphenamine concurrently with another type of antihistamine, such as a non-drowsy one?

Official regulatory warnings state that co-administration with other antihistamine-containing products is restricted. This restriction is noted to prevent cumulative effects, such as increased drowsiness or other central nervous system side effects.


Q: Are people with an enlarged prostate described as needing caution or monitoring when using Chlorphenamine?

Official guidance advises caution for individuals with conditions like prostatic hypertrophy (an enlarged prostate). This is because the medicine has anticholinergic properties that may potentially increase the likelihood of certain pre-existing urinary complications.


Q: Is the drowsy side effect of Chlorphenamine potentially stronger or more pronounced in older adults?

Yes, official documents note that older adults are more susceptible to neurological effects. This means they are more likely to experience increased drowsiness, dizziness, and confusion compared to younger populations, and may be prescribed a lower daily dose.


Q: Are there specific research studies that have examined the long-term safety profile of Chlorphenamine?

Regulatory reviews of the medicine's evidence note that the available research largely consists of short-term studies. Therefore, the safety profile over periods of many months or years is not fully established.


Q: Can Chlorphenamine be used for skin rashes that are not caused by seasonal allergies?

Yes, official indications state the medicine is approved for the symptomatic relief of various allergic conditions, including urticaria (hives) and certain other pruritic (itchy) skin disorders. Its use is focused on relieving the physical discomfort associated with these conditions.


Q: What kind of allergies is Chlorphenamine described as treating in official regulatory documents?

According to official uses listed in regulatory documents, the medicine is indicated for relieving symptoms associated with hay fever (allergic rhinitis), allergic conjunctivitis, upper respiratory allergies, and hives (urticaria).


Q: Does Chlorphenamine work to reduce symptoms associated with the common cold?

Combination products containing this medicine are indicated for common cold symptoms. However, regulatory reviews of the evidence for Chlorphenamine used alone for cold symptoms note that the certainty of that research is low.


Q: Does long-term use of Chlorphenamine have documented effects on memory or cognitive function?

While clinical trials are generally short-term, expert reviews have discussed that cumulative, long-term use of this class of medication may affect memory and cognitive function. This information highlights a common area of discussion associated with the use of first-generation antihistamines.


Q: Does taking Chlorphenamine make a person more sensitive to the sun or cause sun reactions?

Regulatory documents list Photosensitivity (an increased sensitivity to sunlight) as a documented adverse reaction to the medicine. This is a potential risk that is noted, though the frequency of this effect is often described as unknown.


Q: Is the active ingredient in liquid or syrup forms of Chlorphenamine the same as in the tablets?

Yes, the core active component is the same in all approved oral formulations, including tablets, syrups, and oral solutions. This component is Chlorphenamine Maleate.


Q: Do any liquid formulations of Chlorphenamine contain trace amounts of alcohol?

Official documentation regarding inactive ingredients indicates that some liquid or syrup formulations may list alcohol among their excipients. The inactive ingredients list on the specific product label will confirm the presence of alcohol.


Q: Can taking Chlorphenamine potentially interfere with or alter the results of an allergy skin test?

Yes, because this medicine is an antihistamine, it works by counteracting the body's natural histamine response. This mechanism is the reason it can interfere with or alter the results of an allergy skin test, which relies on that histamine response for an accurate reading.


Q: Why does Chlorphenamine sometimes cause a feeling of being 'wired' or overly active instead of sleepy?

This documented adverse effect is known as paradoxical excitation (or paradoxical reaction). It is an effect where the medicine causes restlessness, nervousness, or hyperactivity instead of drowsiness, and it is particularly noted in children and the elderly.


Q: Are there official statements regarding Chlorphenamine and its anticholinergic burden?

Regulatory documents state that the medicine possesses anticholinergic activity. This activity causes specific side effects like dry mouth and blurred vision and is the underlying pharmacological basis for the clinical term 'anticholinergic burden.'


Q: Why is Chlorphenamine sometimes suggested for people whose allergy symptoms interfere with sleep?

Due to its mechanism, Chlorphenamine has well-recognized sedative properties that cause drowsiness. This effect may be a factor in its use when allergy symptoms are severe enough to disrupt a person's ability to sleep.


Q: Are there special considerations for people with severe high blood pressure or cardiovascular disease who use Chlorphenamine?

Official guidance advises caution for individuals with severe high blood pressure or cardiovascular disease. Documented adverse effects of the medicine include palpitations and tachycardia (fast heart rate).


Q: What are the signs of a serious or allergic reaction to Chlorphenamine that are mentioned in official sources?

Signs of a serious allergic reaction listed in official sources include hives, difficult breathing, or swelling of the face, lips, tongue, or throat. These types of serious reactions are generally described as rare in regulatory documents.

Advertisements

How should Chloramine (Chlorphenamine) be stored and disposed of?

Official Storage and Disposal Guidelines

Regulatory documents outline specific requirements for storing and disposing of Chloramine (Chlorphenamine) to ensure product stability and safety. The medication should be stored at room temperature, typically between 20 C to 25 C, or as stated on the label (often le 25 C or le 30 C). It is mandatory to protect the medicine from excess heat, moisture, and light.


Key Regulatory Mandates

Area Requirement
Container & Protection Keep in the original container, tightly closed. Avoid storing in high-humidity areas like the bathroom.
Child Safety Keep out of the sight and reach of children at all times.
Disposal Method Do not flush down the toilet. Utilize a community drug take-back program or mix with an undesirable substance (like coffee grounds) in a sealed bag before placing in household trash.
Stability Note Unused portions of the injection solution must be discarded immediately after opening the ampoule.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Chloramine (Chlorphenamine) found in:

A-Z Index: